Cargando…
Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors
Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067363/ https://www.ncbi.nlm.nih.gov/pubmed/35467965 http://dx.doi.org/10.1200/CCI.21.00163 |
_version_ | 1784699992106074112 |
---|---|
author | Chalkidis, George McPherson, Jordan Beck, Anna Newman, Michael Yui, Shuntaro Staes, Catherine |
author_facet | Chalkidis, George McPherson, Jordan Beck, Anna Newman, Michael Yui, Shuntaro Staes, Catherine |
author_sort | Chalkidis, George |
collection | PubMed |
description | Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid tumors receiving care at a major cancer center from 2014 to 2020. We identified TDPs for new lines of therapy (LoTs) and confirmed mortality at 6 months after a TDP. Using extreme gradient boosting, ML models were developed, which used or derived features from a limited set of electronic health record data considering the literature, clinical relevance, variability, availability, and predictive importance using Shapley additive explanations scores. We predicted and observed 6-month mortality after a TDP and assessed a risk stratification strategy with different risk thresholds to support communication of chance of survival. RESULTS: Four thousand one hundred ninety-two patients were included. Patients had 7,056 TDPs, for which the 6-month mortality increased from 17.9% to 46.7% after starting first to sixth LoT, respectively. On the basis of internal validation, models using both 111 (Full) or 45 (Limited-45) features accurately predicted 6-month mortality (area under the curve ≥ 0.80). Using a 0.3 risk threshold in the Limited-45 model, the observed 6-month survival was 34% (95% CI, 28 to 40) versus 81% (95% CI, 81 to 82) among those classified with low or higher chance of survival, respectively. The positive predictive value of the Limited-45 model was 0.66 (95% CI, 0.60 to 0.72). CONCLUSION: We developed and validated a ML model using a limited set of 45 features readily derived from electronic health record data to predict 6-month prognosis in patients with advanced solid tumors. The model output may support shared decision making as patients consider the next LoT. |
format | Online Article Text |
id | pubmed-9067363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-90673632022-05-04 Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors Chalkidis, George McPherson, Jordan Beck, Anna Newman, Michael Yui, Shuntaro Staes, Catherine JCO Clin Cancer Inform ORIGINAL REPORTS Patients with advanced solid tumors may receive intensive treatments near the end of life. This study aimed to create a machine learning (ML) model using limited features to predict 6-month mortality at treatment decision points (TDPs). METHODS: We identified a cohort of adults with advanced solid tumors receiving care at a major cancer center from 2014 to 2020. We identified TDPs for new lines of therapy (LoTs) and confirmed mortality at 6 months after a TDP. Using extreme gradient boosting, ML models were developed, which used or derived features from a limited set of electronic health record data considering the literature, clinical relevance, variability, availability, and predictive importance using Shapley additive explanations scores. We predicted and observed 6-month mortality after a TDP and assessed a risk stratification strategy with different risk thresholds to support communication of chance of survival. RESULTS: Four thousand one hundred ninety-two patients were included. Patients had 7,056 TDPs, for which the 6-month mortality increased from 17.9% to 46.7% after starting first to sixth LoT, respectively. On the basis of internal validation, models using both 111 (Full) or 45 (Limited-45) features accurately predicted 6-month mortality (area under the curve ≥ 0.80). Using a 0.3 risk threshold in the Limited-45 model, the observed 6-month survival was 34% (95% CI, 28 to 40) versus 81% (95% CI, 81 to 82) among those classified with low or higher chance of survival, respectively. The positive predictive value of the Limited-45 model was 0.66 (95% CI, 0.60 to 0.72). CONCLUSION: We developed and validated a ML model using a limited set of 45 features readily derived from electronic health record data to predict 6-month prognosis in patients with advanced solid tumors. The model output may support shared decision making as patients consider the next LoT. Wolters Kluwer Health 2022-04-25 /pmc/articles/PMC9067363/ /pubmed/35467965 http://dx.doi.org/10.1200/CCI.21.00163 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | ORIGINAL REPORTS Chalkidis, George McPherson, Jordan Beck, Anna Newman, Michael Yui, Shuntaro Staes, Catherine Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title | Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title_full | Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title_fullStr | Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title_full_unstemmed | Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title_short | Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors |
title_sort | development of a machine learning model using limited features to predict 6-month mortality at treatment decision points for patients with advanced solid tumors |
topic | ORIGINAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067363/ https://www.ncbi.nlm.nih.gov/pubmed/35467965 http://dx.doi.org/10.1200/CCI.21.00163 |
work_keys_str_mv | AT chalkidisgeorge developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors AT mcphersonjordan developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors AT beckanna developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors AT newmanmichael developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors AT yuishuntaro developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors AT staescatherine developmentofamachinelearningmodelusinglimitedfeaturestopredict6monthmortalityattreatmentdecisionpointsforpatientswithadvancedsolidtumors |